Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

State of the Art and Next Questions: Aggressive B-Cell Lymphomas

SOHO Highlights: State of the Art and Next Questions

G. Nowakowski

Hematopathology Tumor Board: Case Studies and Diagnostic Challenges …

UChicago Medicine

G. Venkataraman, A. Perry, K. Cahill, A. Akmatbekov, L. Wu

Safety Profile of Ruxolitinib in Patients With MF

Icahn School of Medicine at Mount Sinai

D. Tremblay

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

ASH 2022 Conference Coverage

M. McMullin

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Insights from 2023 ASH Annual Meeting

D. Tremblay

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

EHA 2024 Insights: Intrathecal Rituximab + Dex for Refractory Sanctu…

Insights from 2024 EHA Annual Meeting

M. Salamoon

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

Monia Marchetti

Treatment-Related Quality of Life in MF

Winship Cancer Institute - Emory University

A. Hunter

2023 SOHO® Brazil: "Moving Beyond CODOX - How Disease Features Can G…

SOHO Brazil 2023

J. Alderuccio

How I Manage Pain in Patients With Cancer

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

H. Çetingök

CD19 CAR-T for Resistant p53+ Burkitt Lymphoma Relapsing Post-AlloHS…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

A. Nagler

SOHO Highlights - State of the Art & Next Questions: Aggressive B-Ce…

SOHO Highlights: State of the Art and Next Questions

L. Sehn

SOHO 2023: Harnessing the Immune System in Patients With Lymphoma

SOHO 2023 Eleventh Annual Meeting

S. Ansell

Prognostication and Treatment of Burkitt Lymphoma in the Modern Era

19th Annual International Ultmann Chicago Lymphoma Symposium

A. Olszewski

Clinical Reasoning: A 7-Year-Old with New-Onset Seizures, Behavior D…

University of Utah Neurology

M. V. Stanich

High-Grade B-Cell Lymphomas, Not Otherwise Specified: How To Differe…

19th Annual International Ultmann Chicago Lymphoma Symposium

D. Scott

EHA 2022 on R-CODOX-M/R-IVAC vs. Dose-Adjusted EPOCH-R in Newly Diag…

ecancer

M. Chamuleau

ASH 2019 Updates on Large Cell Lymphoma: Use of ClonoSEQ in Diagnosi…

Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

S. Nasta